Rxsight
Quarterly Financials
| Values in thousands | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
Revenue | $24,586 | $33,741 | $30,893 | $32,607 |
Gross Profit | 18,099 | 25,886 | 23,498 | 25,263 |
EBITDA | -15,264 | -11,007 | -15,041 | -8,290 |
EBIT | -16,193 | -12,006 | -15,875 | -9,141 |
Net Income | -16,224 | -12,097 | -15,884 | -9,151 |
Net Change In Cash | 24,586 | 33,741 | 30,893 | 32,607 |
Free Cash Flow | 44,042 | -11,494 | -11,650 | -2,253 |
Cash | 66,717 | 13,352 | 17,573 | 19,949 |
Basic Shares | 41,705 | 41,490 | 41,306 | 41,175 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $134,477 | $139,927 | $89,077 | $49,005 |
Gross Profit | 103,008 | 98,943 | 53,765 | 21,328 |
EBITDA | -35,570 | -23,760 | -41,037 | -57,779 |
EBIT | -38,836 | -27,384 | -45,280 | -61,801 |
Net Income | -38,943 | -27,455 | -48,608 | -66,756 |
Net Change In Cash | 134,477 | 139,927 | 89,077 | 49,005 |
Cost of Revenue | -12,568 | |||
Free Cash Flow | -19,341 | -22,386 | -46,407 | -61,243 |
Cash | 19,949 | 16,706 | 9,692 | 11,834 |
Basic Shares | 41,175 | 38,867 | 34,455 | 27,661 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-09-30 | -$0.39 |
2026-06-30 | -$0.29 |
2026-03-31 | -$0.19 |
2025-12-31 | -$0.03 |